samedan logo
home > pmps > summer 2003 > making the best possible use of an industrial freeze drier
Pharmaceutical Manufacturing and Packing Sourcer

Making the Best Possible Use of an Industrial Freeze Drier

This article investigates measures that can be taken to ensure that industrial freeze dryers remain competitive in the field of freeze-dried medicine production after 15 years of intensive use and still operate at the highest European standards.
The Production Line

For the aseptic filling and freeze drying of bottled products the following steps can be taken:

Wash on FAW1000 Bausch and Ströbel
Sterilisation/depyrogenation in radiant tunnel DST4047 Bausch and Ströbel
Filling KSF1020 Bausch and Ströbel
Freeze drying in Cirp CS60/6
- Classic on KS1020 Bausch and Ströbel
- Special on Marchesini ML657
- Technical data
- capacity to deal with bottles ranging from the standard 2R to the standard 30R to a maximal actual cadence of 3,600 bottles per hour
Environment: A, B, A/B classes according to the European Guide of the Good Practices of Manufacture (capping in A class)

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

By M Roubertou Jean-Yves, Head Pharmacist and General Manager at Elaiapharm

Mr Roubertou has been Head Pharmacist and Managing Director of the Elaiapharm Laboratory, a company manufacturing dry, sterile and liquid forms, since 2000. He was awarded a diploma by the Faculty of Pharmacy of the University of Paris and had special basic school-leaving qualification of biology and an engineering degree in biotechnology at the University of Rennes. He is a qualified Pharmacist.

His career in biochemistry began in the hospitals of Paris before he became Director of a hospital-based laboratory of biochemistry. After 10 years of hospital-based work, Mr Roubertou began an industrial career with responsibility for the control and development of the laboratory before becoming Head Pharmacist at Panpharma Laboratory, specialising in the aseptic distribution of parenteral powders.

M Roubertou Jean-Yves
Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st – 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement